Back to Results
First PageMeta Content
Glioma / Glioblastoma multiforme / DOTA / Positron emission tomography / Immunohistochemistry / Astrocytoma / Radiopharmacology / Medicine / Brain tumor / Oligodendroglioma


Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with 68Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy
Add to Reading List

Open Document

File Size: 1,15 MB

Share Result on Facebook

City

Glostrup / Duiven / Munich / Kalamazoo / Hamburg / Strasbourg / Turku / Billerica / Cambridge / Chicago / /

Company

SPSS Inc. / Millipore / PET / M Recurrent S RT C / Acknowledgements Laboratory / GE / Dynamic PET / Thermo Scientific Inc / Pearson / Cox / Creative Commons / /

Country

Netherlands / France / United Kingdom / Finland / Denmark / Germany / United States / /

Currency

pence / /

/

Event

M&A / /

Facility

PET Centre / Hospital District / University of Turku / Medical Imaging Centre of Southwest / Turku University Hospital / /

IndustryTerm

magnetic resonance imaging / imaging / receptor imaging / receptor imaging findings / in-house developed software / clinical applications / Online Resource / online submission / performed using in-house developed software / /

MedicalCondition

anaplastic glioma demonstrating SUVmax / high-grade gliomas / High-grade glioma / neuroendocrine tumors / Tumor PET / recurrent glioblastomas / Tumor SUVmax / astrocytomas / malignant glioma patients / anaplastic oligodendrogliomas / oligodendrogliomas / tumor 68Ga-DOTA-peptide uptake / common primary malignant brain tumors / recurrent high-grade glioma / Contrast-enhanced tumor / glioblastoma / Tumor / diffuse gliomas / Cancer / tumors / neuroblastoma tumor / glioblastomas / anaplastic gliomas / TCGA glioblastoma data / IDH1 wild-type gliomas / glioma grade / astrocytoma / Background High-grade gliomas / intracranial tumours / Genes Chromosomes Cancer / inhibited tumor / meningioma / colorectal cancer / glioma / J Cancer / central nervous system tumors / meningiomas / gliomas / numbness / low-grade and high-grade astrocytomas / gliosarcoma / primary and metastatic pancreatic cancer / normalized tumor / human gliomas / pancreatic neuroendocrine tumors / childhood neuroblastomas / necrosis / oligodendroglioma component / dyspnea / SSTR2-positive neuroendocrine tumors / oligodendroglial tumor / mild claustrophobia / oligodendroglioma / experimental pancreatic tumors / pancreatic carcinoma / mixed oligoastrocytomas / medulloblastomas / extra-axial meningiomas / /

MedicalTreatment

radiotherapy / surgery / targeted radiotherapy / Neurosurgery / chemotherapy / /

Organization

Turku PET Centre / World Health Organization / Turku University Hospital / Department of Oncology and Radiotherapy / University of Turku / Medical Imaging Centre / Cancer Society of Finland and Southwest Finland Hospital District / Finnish Medicines Agency / Ethics Committee of the Hospital District / Department of Pathology / Graduate School / PET Centre / 6Turku Center for Disease Modeling / /

Person

Scanner / Logan J. Graphical / Sze Chan / S III OA / performed using a GE Discovery VCT PET/CT Scanner / /

Position

automatic fusion using iPlan RT / RT / author / representative / MP / Fisher / /

Product

Local injection / M-16 / DTPA / dexamethasone / SSTR2 / PET SSTR2 / /

ProvinceOrState

Connecticut / /

Region

Southwest Finland / /

TVStation

Kida / /

Technology

magnetic resonance imaging / gene expression / chemotherapy / Neurosurgery / Medical Imaging / tomography / Antibodies / hybridization / radiopharmaceuticals / MRI / /

URL

http /

SocialTag